Vision is essential for humans, with mammals able to detect visible light between 400 and 700 nm on the electromagnetic spectrum. In mammalian photoreceptor cells, light-absorbing pigments, consisting of opsins … Continue Reading Augmented injection gives mammals night vision.
Heart surgery may seem like a standard procedure in this modern age, however, there is always a danger that the patient’s blood may coagulate or clot too quickly, both of … Continue Reading Light beam replaces blood tests during human heart surgery.
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impaired social communication and interaction, and restricted, repetitive patterns of behaviour. Approximately 1 in 70 children are diagnosed with ASD … Continue Reading Researchers identify new blood-based biomarker for boys with autism.
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterised by abdominal pain and altered bowel habits. IBS has a high prevalence of up to 15% among the general population … Continue Reading Breath-test used to diagnose irritable bowel syndrome in large human study.
Melanoma incidence has been rapidly increasing worldwide, with fewer than 10% of people whose melanoma tumours have spread or metastasized surviving longer than a decade after detection. Despite the considerable … Continue Reading New ctDNA blood-test for melanoma beats standardised test in human trials.
In Alzheimer’s, the brain begins to change years before symptoms emerge. Detecting Alzheimer’s antibodies at the preclinical stage would give patients an opportunity to work with their physician to make … Continue Reading Researchers nearing a blood test for Alzheimer’s disease.
In the UK liver disease has risen sharply over the past few decades and is the third biggest cause of premature mortality, with three quarters of liver deaths due to … Continue Reading Human study identifies definitive biomarker for liver disease breath test.
After a hit to the head or rapid whiplash, whether from a car crash, athletic event or other accident, millions of Americans develop traumatic brain injuries (TBIs) each year. TBIs … Continue Reading Large-scale human study shows blood test predicts prognosis for traumatic brain injuries.
Individuals with amnestic mild cognitive impairment (aMCI) are at twice the risk of others in their age group of progressing to Alzheimer’s disease. Currently there is no conclusive test that … Continue Reading Non-invasive neuroimaging marker shows great potential for Alzheimer’s risk detection.
A new non-invasive scan can be used to determine the extent of plaque buildup in the heart accurately predicts the likelihood of heart attack or death over a 15-year period. … Continue Reading New non-invasive test predicts long-term death risk in humans even without heart disease symptoms.
On the hunt for better cancer screening tests, Johns Hopkins researchers led a proof of principle study that successfully identified tumour DNA shed into the blood and saliva of 93 … Continue Reading DNA shed from human head and neck tumours detected in blood and saliva for the first time.
New technology developed by Howard Hughes Medical Institute (HHMI) and Brigham and Women’s Hospital researchers makes it possible to test for current and past infections with any known human virus by … Continue Reading New bacteriophage-based assay gives a person’s whole viral infection history in a drop of blood.
Another step forward has just been taken in the area of synthetic biology. Research teams from Inserm, CNRS (French National Centre for Scientific Research), Montpellier Regional University Hospital and Stanford … Continue Reading Intelligent bacteria, bactodetectors, have been programmed to successfully detect disease.
Investigators at the Stanford University have identified a pattern of gene activity that could help scientists create a blood test for quickly and accurately detecting whether patients are experiencing a … Continue Reading Researchers identify the genetic signature for early, accurate sepsis diagnosis.
A test that costs less than a $1 and yields results in minutes has been shown in newly published studies to be more sensitive and more exact than the current … Continue Reading Study finds $1 test using gold nanoparticles outperforms PSA screen for prostate cancer.
A blood test undertaken between 10 to 14 weeks of pregnancy may be more effective in diagnosing Down syndrome and two other less common chromosomal abnormalities than standard non-invasive screening … Continue Reading New blood test has higher accuracy than standard screening for Down Syndrome in early pregnancy.